Petros Grivas, MD, PhD

/content/dam/www/faculty-photos/G/petros-grivas/petros-grivas.jpg
Dr. Petros Grivas MD, PhD

Follow Petros Grivas

FACULTY MEMBER

Petros Grivas, MD, PhD

Professor, Clinical Research Division, Fred Hutch

Professor
Clinical Research Division, Fred Hutch

Clinical Director, Genitourinary Cancers Program, Fred Hutch

Clinical Director
Genitourinary Cancers Program, Fred Hutch

Dr. Petros Grivas is an oncologist with expertise in treating genitourinary cancers such as bladder cancer, prostate cancer and testicular cancer. His clinical research helped lead to FDA approval of new drugs to treat the most common type of bladder cancer. Dr. Grivas currently leads clinical trials that investigate the use of checkpoint inhibitors. These immunotherapy drugs release the brakes on a patient’s immune system and help it mount a better response to cancer. 

Other Appointments & Affiliations

Professor, Division of Hematology and Oncology, University of Washington School of Medicine

Professor, Division of Hematology and Oncology
University of Washington School of Medicine

Education

Fellowship, Hematology/Oncology, University of Michigan

Residency, Drexel University College of Medicine/Hahnemann University Hospital, Philadelphia, PA

PhD, Medical Oncology, University of Patras School of Medicine, Greece

MD, University of Patras School of Medicine, Greece